Terms: = Ovarian cancer AND RUNX1T1, ENSG00000079102, 862 AND Diagnosis
8 results:
1. Concurrent Surgery for Locoregional Gynecologic cancers and Pelvic Floor Disorders in a Population of Patients With Medicare Insurance.
Corey L; Seaton R; Ruterbusch JJ; Bretschneider CE; Vezina A; Do T; Hobson D; Winer I
Obstet Gynecol; 2023 Apr; 141(4):629-641. PubMed ID: 36897144
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative assessment using the five-factor modified frailty index: A call for standardized preoperative assessment and prehabilitation services in gynecologic oncology.
AlHilli MM; Schold JD; Kelley J; Tang AS; Michener CM
Gynecol Oncol; 2022 Sep; 166(3):379-388. PubMed ID: 35863992
[TBL] [Abstract] [Full Text] [Related]
3. Tobacco Smoking and Survival Following a diagnosis with ovarian cancer.
Wang T; Read SH; Moino D; Ayoubi Y; Chern JY; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1376-1382. PubMed ID: 35775222
[TBL] [Abstract] [Full Text] [Related]
4. Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor runx1t1.
Sun T; Yang P; Gao Y
Exp Physiol; 2020 Jan; 105(1):75-87. PubMed ID: 31645082
[TBL] [Abstract] [Full Text] [Related]
5. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
[TBL] [Abstract] [Full Text] [Related]
6. cancer antigens 19.9 and 125 as tumor markers in patients with mucinous ovarian tumors.
Santotoribio JD; Garcia-de la Torre A; Cañavate-Solano C; Arce-Matute F; Sanchez-del Pino MJ; Perez-Ramos S
Eur J Gynaecol Oncol; 2016; 37(1):26-9. PubMed ID: 27048105
[TBL] [Abstract] [Full Text] [Related]
7. Bowel obstruction in elderly ovarian cancer patients: a population-based study.
Mooney SJ; Winner M; Hershman DL; Wright JD; Feingold DL; Allendorf JD; Neugut AI
Gynecol Oncol; 2013 Apr; 129(1):107-12. PubMed ID: 23274561
[TBL] [Abstract] [Full Text] [Related]
8. Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women.
Jeyarajah AR; Ind TE; Skates S; Oram DH; Jacobs IJ
Cancer; 1999 May; 85(9):2068-72. PubMed ID: 10223249
[TBL] [Abstract] [Full Text] [Related]
